跳至主要内容
临床试验/NCT06363864
NCT06363864尚未招募不适用

Investigation of Metabolite Differences Between Taiwanese Metabolic Syndrome and Healthy Group Through Metabolomics

Leeuwenhoek Laboratories Co. Ltd.0 个研究点目标入组 1,200 人开始时间: 2024年4月14日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
1,200
主要终点
Concentration changes of small molecules in blood.

研究概览

简要总结

The prevalence of metabolic syndrome in Taiwan has been increasing yearly. In this project, the database of blood test results from healthy and metabolic syndromes individuals will be analyzed to identify the small molecules related to the severity of metabolic syndrome. These identified small molecules could be used as biomarkers to predict the development of metabolic syndromes in the future.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Capable adults weigh ≥ 50 kg

排除标准

  • Not Taiwanese
  • Having received oral antibiotics, immunosuppressants, and chemotherapy drugs in the past month
  • Incapacity
  • Limited disposing capacity
  • Mental disorders or intellectual disabilities

结局指标

主要结局

Concentration changes of small molecules in blood.

时间窗: Up to six years

Concentrations of small molecules in healthy individuals and metabolic syndrom patients will be analyzed to identify specific biomarkers for metabolic syndrome.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验